NPEC(600775)
Search documents
南京熊猫: 南京熊猫2024年年度股东大会决议公告

Zheng Quan Zhi Xing· 2025-06-20 11:11
| 证券代码:600775 证券简称:南京熊猫 公告编号:2025-017 | | | | | --- | --- | --- | --- | | 南京熊猫电子股份有限公司 | | | | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 | | | | | 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 | | | | | 重要内容提示: | | | | | 本次会议是否有否决议案:无 | ? | | | | 一、 会议召开和出席情况 | | | | | (一)股东大会召开的时间:2025 年 6 月 20 日 | | | | | (二)股东大会召开的地点:南京市经天路 7 号公司会议室 | | | | | (三)出席会议的普通股股东及其持有股份情况: | | | | | 其中:A 股股东人数 646 | | | | | 境外上市外资股股东人数(H 股) 1 | | | | | 其中:A 股股东持有股份总数 241,370,941 | | | | | 境外上市外资股股东持有股份总数(H 13,768,000 股) | | | | | 份总数的比例(%) | | | | ...
南京熊猫(600775) - 国浩律师(南京)事务所关于南京熊猫2024年年度股东大会之法律意见书

2025-06-20 10:15
2024 年年度股东大会 国浩律师(南京)事务所 法律意见书 国浩律师(南京)事务所 关 于 南京熊猫电子股份有限公司 之 法律意见书 中国江苏省南京市汉中门大街 309 号 B 座 5、7-8 层(210036) 5、7-8/F, Block B, 309 Hanzhongmen Dajie, Nanjing, China, 210036 电话/Tel: +86-25-89660900 传真/Fax: + 86-25-89660966 网址/Website:http://www.grandall.com.cn 2025 年 6 月 国浩律师(南京)事务所 法律意见书 国浩律师(南京)事务所 关于南京熊猫电子股份有限公司 2024 年年度股东大会之法律意见书 致:南京熊猫电子股份有限公司 根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共 和国证券法》(以下简称"《证券法》")和中国证券监督管理委员会《上市公司 股东大会规则》(以下简称"《股东大会规则》")的规定,国浩律师(南京)事 务所(以下简称"本所")接受南京熊猫电子股份有限公司(以下简称"公司")董 事会的聘请,指派景忠律师、杨菲律 ...
南京熊猫(600775) - 南京熊猫2024年年度股东大会决议公告

2025-06-20 10:15
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 本次会议是否有否决议案:无 证券代码:600775 证券简称:南京熊猫 公告编号:2025-017 南京熊猫电子股份有限公司 2024年年度股东大会决议公告 一、 会议召开和出席情况 (一)股东大会召开的时间:2025 年 6 月 20 日 (二)股东大会召开的地点:南京市经天路 7 号公司会议室 (三)出席会议的普通股股东及其持有股份情况: | 1、出席会议的股东和代理人人数 | 647 | | --- | --- | | 其中:A 股股东人数 | 646 | | 境外上市外资股股东人数(H 股) | 1 | | 2、出席会议的股东所持有表决权的股份总数(股) | 255,138,941 | | 其中:A 股股东持有股份总数 | 241,370,941 | | 境外上市外资股股东持有股份总数(H 股) | 13,768,000 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 27.92 | | 份总数的比例(%) | | | 其中:A 股股东持 ...
南京熊猫: 南京熊猫关于公开挂牌转让参股公司股权的公告
Zheng Quan Zhi Xing· 2025-06-19 09:22
Summary of Key Points Core Viewpoint - Nanjing Panda Electronics Co., Ltd. plans to publicly transfer 27% of its stake in the subsidiary Nanjing Ericsson Panda Communication Co., Ltd. (ENC) through the Shanghai United Assets and Equity Exchange, with a total valuation of the equity held by all shareholders at approximately RMB 105.41 million as of December 31, 2024 [2][3][8]. Group 1: Transaction Overview - The company intends to transfer its 27% stake in ENC, which will be combined with the stakes held by other Chinese shareholders, totaling 49% of ENC [2][4]. - The initial transfer price for the 49% stake is set at RMB 51.65 million, with the company's corresponding stake valued at RMB 28.46 million [3][6]. - If no interested buyers are found during the disclosure period, the transfer price may be reduced to a minimum of 90% of the initial price, resulting in a new price of RMB 46.49 million for the 49% stake [3][6]. Group 2: Financial Information - The total assets of ENC as of the latest unaudited report are RMB 265.63 million, with total liabilities of RMB 163.51 million, resulting in a net asset value of RMB 102.12 million [7][8]. - The revenue for ENC in the most recent period was RMB 337.61 million, with a net profit after deducting non-recurring gains and losses [8]. Group 3: Valuation and Pricing - The valuation of ENC was conducted by Beijing Zhongtianhua Asset Appraisal Co., Ltd., which determined the total equity value at RMB 105.41 million as of December 31, 2024 [8][12]. - The valuation methods used include the income approach and market approach, with the market approach deemed more reflective of the equity's value due to the nature of the transaction [12][13]. - The pricing for the transfer adheres to national asset supervision regulations, ensuring fairness and objectivity in the valuation process [15]. Group 4: Transaction Process - The transaction will be conducted through a public bidding process, with the final buyer and transaction price determined based on the results of the bidding [16][17]. - The company will follow the necessary approval procedures and disclose relevant information as required by regulations [17]. Group 5: Impact on the Company - The completion of this equity transfer is expected to have a positive impact on the company's financials, with the actual amount to be confirmed post-transaction [18].
南京熊猫(600775) - 南京熊猫拟处置股权所涉及的南京爱立信熊猫通信有限公司股东全部权益估值报告

2025-06-19 08:30
南京熊猫电子股份有限公司拟处置股权 所涉及的南京爱立信熊猫通信有限公司 股东全部权益价值 信值报告 中天华咨报字[2025]第2142号 (共一册, 第一册) 北京中i 责任公司 l 南京熊猫电子股份有限公司拟处置股权所涉及的 南京爱立信熊猫通信有限公司股东全部权益价值估值报告 目录 | 声 | 明 .. | | --- | --- | | 估值报告摘要 | | | 估值报告 | | | 一、 委托人、被估值单位和估值业务委托合同约定的其他估值报告使用人概况….6 | | | 二、 | 估值目的…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………… 11 | | 估值对象和估值范围 …………………………………………………………………………………………………………………………………………… 12 | | | 价值类型 ……………………………………………………………………………………………………………………………………………………………………………………………………… ...
南京熊猫(600775) - 南京熊猫关于公开挂牌转让参股公司股权的公告

2025-06-19 08:30
证券代码:600775 证券简称:南京熊猫 公告编号:临 2025-016 南京熊猫电子股份有限公司 关于公开挂牌转让参股公司股权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、交易概述 (一)本次交易的基本情况 南京熊猫电子股份有限公司(以下简称"公司")拟通过上海联合产权交易 所有限公司(以下简称"上海联合产权交易所")公开挂牌转让所持有的参股公 司南京爱立信熊猫通信有限公司(以下简称"ENC")27%的股权(以下简称"标 的股权")。本次转让的标的股权将与中电科资产经营有限公司持有的 ENC20% 的股权、香港永兴企业公司持有的 ENC2%的股权一并公开挂牌。公司、中电科 1 公司拟通过上海联合产权交易所公开挂牌转让所持有的参股公司 ENC27% 的股权。本次转让的标的股权将与其他 ENC 中方股东持有的 ENC22%的股 权一并公开挂牌。根据有关《估值报告》,确定前述 ENC49%的股权公开挂 牌转让底价为人民币 51,650.85 万元,公司所持标的股权对应价值为人民币 28,460.67 ...
脑机接口板块直线拉升 创新医疗涨停
news flash· 2025-06-19 01:41
Group 1 - The brain-computer interface sector has experienced a significant surge, with companies like Innovation Medical (002173) hitting the daily limit up [1] - Other companies such as Beikang, Aipeng Medical (300753), Nanjing Panda (600775), Entropy Technology (301330), and Sanbo Brain Science (301293) have also seen notable increases in their stock prices [1] - There is a notable influx of dark pool capital into these stocks, indicating potential investor interest and activity [1]
脑机接口“杀疯了” 概念股集体狂飙
Mei Ri Shang Bao· 2025-06-17 22:20
Group 1 - The brain-computer interface (BCI) concept has seen a significant surge, with related stocks experiencing substantial gains, including Beiyikang reaching a "30CM" limit up and Aipeng Medical hitting a "20CM" limit up [1][2] - The first humanoid robot full industry chain exhibition in China is set to take place on June 20 in Hangzhou, featuring Tesla and Yushu, showcasing advanced technologies including bionic drive and BCI [1][4] - The BCI market in China is projected to reach 5.58 billion yuan by 2027, indicating rapid growth and commercialization potential [1][6] Group 2 - Chinese concept stocks related to BCI have seen a significant rise, with companies like Aipeng Medical and Nanjing Panda Electronics experiencing limit up and substantial gains [2][3] - Nanjing Panda Electronics is developing a multimodal human-computer interaction system based on BCI technology, targeting applications in medical rehabilitation and smart wearables [3] - The market for BCI applications is expected to reach hundreds of billions of dollars, driven by various favorable developments and advancements in technology [4][6] Group 3 - The global BCI market is estimated to reach between 4 billion to 145 billion dollars in the medical field by 2030-2040, with non-invasive products currently leading commercialization [5][6] - The global BCI market size reached 1.98 billion dollars in 2023, with expectations to exceed 6 billion dollars by 2028, reflecting a compound annual growth rate of 25.22% [6]
政策、技术、资本协同共振 脑机接口产业蓄势腾飞
Zheng Quan Ri Bao· 2025-06-17 16:09
Core Insights - The brain-computer interface (BCI) industry is experiencing explosive growth driven by policy incentives, technological innovations, and increased capital investment [1][2][3] Policy Framework Development - 2025 is identified as a critical year for the establishment of a comprehensive policy framework for the BCI industry, including national standards and regional industrial planning [2] - Beijing and Shanghai are leading the way with specific action plans aimed at fostering BCI innovation and development [2][3] - The establishment of a standardization technical committee by the Ministry of Industry and Information Technology will promote the standardized development of BCI technology [3] Technological Innovations - Recent advancements in multi-disciplinary technology integration have significantly propelled BCI development, transitioning from "signal acquisition" to "bidirectional interaction" [4][5] - Breakthroughs in deep learning algorithms and hardware technologies are enhancing the efficiency of brain signal decoding and reducing risks associated with invasive procedures [4][5] Industry Progression - The dual benefits of favorable policies and technological advancements are attracting significant capital investment, with companies like Sanbo Brain Hospital Management Group and Beijing Chengyitong Control Technology Group actively engaging in BCI development [6][7] - Companies are focusing on both invasive and non-invasive BCI technologies, with notable advancements in clinical applications for conditions like epilepsy and Parkinson's disease [6][7] Market Potential - The BCI market in China is projected to reach 3.2 billion yuan in 2024, with expectations to exceed 5.5 billion yuan by 2027 [8] - The global BCI medical application market is forecasted to reach between 40 billion to 145 billion USD from 2030 to 2040, indicating substantial market potential [8][9] Challenges Ahead - Despite the promising outlook, the BCI industry faces challenges such as medical ethics review, clinical validation, and the need for unified industry standards [9]
南京熊猫电子股份近一个月首次现身港股通成交活跃榜 净买入1.65亿港元

Zheng Quan Shi Bao Wang· 2025-06-17 13:39
6月17日上榜港股通成交活跃榜个股中,南京熊猫电子股份为近一个月首次上榜。 证券时报·数据宝统计显示,6月17日港股通(包括沪市港股通及深市港股通)成交活跃股合计成交 315.58亿港元,占当日港股通成交金额的27.71%,净买入金额13.18亿港元。 上榜的成交活跃股中,泡泡玛特成交额为54.70亿港元,成交金额居首;其次是山东墨龙、阿里巴巴- W,成交金额分别为51.32亿港元、35.36亿港元。 南京熊猫电子股份为近一个月首次上榜,当日港股通成交额为17.35亿港元,成交净买入1.65亿港元,该 股当日收盘上涨38.02%。(数据宝) 6月17日港股通成交活跃股榜单 | 证券 | 证券简称 | 成交金额(亿 | 净买入金额(亿 | 近一个月上 | 最新收盘价 | 日涨跌幅 | | --- | --- | --- | --- | --- | --- | --- | | 代码 | | 港元) | 港元) | 榜次数 | (港元) | (%) | | 00700 | 腾讯控股 | 21.41 | -7.14 | 21 | 513.500 | 0.79 | | 01810 | 小米集团-W | 23.25 | ...